US Patent

US7737168 — Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases

Method of Use · Assigned to Siga Technologies Inc · Expires 2031-09-04 · 5y remaining

Vulnerability score 76/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects methods of using certain compounds for the treatment or prevention of viral infections and diseases caused by the orthopoxvirus.

USPTO Abstract

Methods of using di, tri, and tetracyclic acylhydrazide derivatives and analogs, as well as pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases cased by the orthopoxvirus.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3377`	—
`U-2346`	—

Patent Metadata

Patent number: US7737168
Jurisdiction: US
Classification: Method of Use
Expires: 2031-09-04
Drug substance claim: No
Drug product claim: No
Assignee: Siga Technologies Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.